- Summit Therapeutics (NASDAQ:SMMT) has appointed Robert LaCaze as chief commercial officer, reporting to Manmeet S. Soni, chief operating officer and chief financial officer, effective immediately.
- LaCaze is a seasoned biopharmaceutical executive with over 35 years of extensive leadership experience in commercial strategy and execution, the company said.
- He has held senior positions at major pharmaceutical companies like Bayer Healthcare and Bristol-Myers Squibb.
- Source: Press Release
More on Summit Therapeutics
Source link
